2m 2m 2m 2m 2m 2m 2m
ALZAMEND (ALZN)
NASDAQ
$1.36+$0.05 (+3.42%)
Price as of Oct 02, 2026 4:27 PM EDT- $6.3MMarket Cap
- -46.76%1-Year Change
- BiotechnologyIndustry
ALZAMEND (ALZN)
$1.36+$0.05 (+3.42%)
ALZN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.31 | ||
Change | -$0.41 (-23.99%) | ||
Open | $1.72 | ||
High | $1.72 | ||
Low | $1.26 | ||
Previous Close | $1.73 | ||
Volume | 150,749 | ||
30-Day Average Volume | 107,116 | ||
1-Week Change | -27.75% | ||
1-Month Change | -19.66% | ||
1-Year Change | -46.76% | ||
3-Year Change | -99.59% | ||
5-Year Change | -99.97% | ||
Fundamentals | |||
Shares Outstanding | 4.8M | ||
Total Assets | $8.5M | ||
Market Cap | $6.3M | ||
Enterprise Value | -$1.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.0M | ||
Free Cash Flow | -$1.1M | ||
EBIT | -$3.0M | ||
EBITDA | -$3.0M | ||
Net Working Capital | $5.5M | ||
EPS | -$0.68 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 9 | ||
Last Split Date | 05/12/2025 | ||
Earnings & Revenue